Multi-Strain Bacterial Control via Toxin-Antitoxin Cycling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlling bacterial populations and delivering therapeutic agents face challenges in maintaining stability of engineered genetic constructs and ensuring specific, timed delivery of therapeutic proteins, as bacteria can mutate or persist in disease environments, leading to ineffective treatment and resource competition.
Innovation Solution
A tri-lysis or multi-lysis system comprising multiple bacterial strains, each producing specific toxins and antitoxins, allowing cyclical population control and targeted delivery of therapeutic proteins by sequentially administering strains that kill or are killed by others, ensuring stability and specific temporal delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If bacterial populations are used to deliver therapeutic agents, then therapeutic delivery capability is improved, but population stability deteriorates due to mutation and persistence in disease environments
Solution Approach 1:
The patent implements preliminary action by designing a pre-determined cyclical toxin-antitoxin system that automatically controls bacterial population dynamics. Strains are engineered with predetermined toxin-antitoxin pairs that will cyclicity eliminate dominant strains before they can mutate or persist indefinitely, ensuring population stability is maintained through pre-programmed biological control mechanisms
Solution Approach 2:
The patent applies periodic action through the implementation of cyclical population control using toxin-antitoxin systems. Each strain produces toxins that kill other strains in a repeating cycle (e.g., Strain A kills Strain B, Strain B kills Strain C, Strain C kills Strain A), creating periodic population fluctuations that prevent any single strain from dominating and mutating, thereby maintaining both therapeutic delivery capability and population stability
2Productivity
If multiple bacterial strains are co-cultured for therapeutic delivery, then therapeutic efficacy is improved through sequential delivery, but system complexity increases
Solution Approach 1:
The patent implements self-service by engineering bacterial strains to autonomously regulate their own population dynamics through内置 toxin-antitoxin systems. Each strain automatically produces toxins that kill other strains in the cycle and antitoxins that protect itself, creating a self-regulating system that eliminates the need for external control mechanisms, thereby managing complexity while maintaining sequential therapeutic delivery
Solution Approach 2:
The patent applies merging by combining multiple functions into each bacterial strain: each strain simultaneously serves as a therapeutic delivery vehicle, a population control agent (producing toxins against other strains), and a self-protection mechanism (producing antitoxins). This consolidation reduces overall system complexity by eliminating the need for separate control systems while maintaining sequential therapeutic delivery efficacy
3Duration of action of moving object
If bacterial strains persist in disease environments for extended periods, then therapeutic delivery duration is improved, but resource competition increases and treatment effectiveness decreases
Solution Approach 1:
The patent applies periodic action by implementing cyclical population control where strains are periodically eliminated through toxin-mediated killing. This creates rhythmic population fluctuations that ensure strains are removed from the disease environment before they can deplete resources or mutate, thereby maintaining therapeutic delivery duration while preventing resource competition and treatment ineffectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system stabilizes gene circuit functionality, enables specific and timed delivery of therapeutic proteins, and maintains ecological balance by removing mutated strains, enhancing therapeutic efficacy and reducing resource competition in disease environments.
Implementation Method 1
each strain produces a toxin, which kills one of the other two strains, and an antitoxin to protect itself
Implementation Method 2
each of the strains can produce a therapeutic protein or a suite of therapeutic proteins, the expression of which can be controlled by a genetic circuit
Data Source
AI summary
Provided herein are multi-strain population control systems, methods, kits, and compositions. Also provided are methods, systems, kits, and compositions for culturing bacterial cells in multi-strain ecosystems, and temporally arranged multi-strain ecosystems or cultures using a synchronized lysis circuit in combination with multiple toxin/antitoxin systems to cycle continuously over a long period of time.